• Home
  • Company
    • Management
    • Board of Directors
    • Advisory Board
  • Technology
    • Publications
  • Partnering
    • Product Pipeline
  • News
    • IN THE PRESS: Cloud Pharmaceuticals CSO Shahar Keinan in "The Scientist"
    • Cloud Pharmaceuticals to Present AI-Based Drug Design at Conferences in May
    • Cloud Pharmaceuticals Wins U.S.-China Health Summit
    • Cloud Pharmaceuticals Selected Finalist in U.S.-China Health Summit
    • Cloud Pharmaceuticals forms Drug Design Collaboration with GSK
    • Cloud Pharmaceuticals CEO to Speak at Artificial Intelligence in Drug Development Congress 27-28 September 2017, London, UK
    • Cloud Pharmaceuticals CEO and CSO to Speak at AI Pharma Innovation
    • Cloud Pharmaceuticals CEO to Speak at the AI in Pharma Summit October17, 2017 in Boston.
    • Cloud Pharmaceuticals CEO and CSO to Speak at AI Pharma Innovation
    • Undruggable? Not to Cloud Pharmaceuticals
    • Cloud Pharmaceuticals Announces Design of Active Pro-Drug for Treatment of Crohn's Disease and Ulcerative Colitis
    • Cloud Pharmaceuticals COO to Discuss Digital Tools for Drug Discovery and Development at the 2016 BIO International Convention
    • Cloud Pharmaceuticals Appoints Neurological Disorder Expert Jeff Vaught to Its Advisory Board
    • Cloud Pharmaceuticals Strengthens Management Team with Appointment of Two C-Level Executives
  • Events
  • Contact
Cloud Pharmaceuticals
Connect with us:

News

Cloud Pharmaceutical's Fujitsu Partnership Has Resulted in a Spinout Venture for Quantum Computing Based Drug Discovery
March, 2020  Accelerating Drug Discovery for 2-4 Years Down to 8 Months
​
IN THE PRESS: Cloud Pharmaceuticals CSO Shahar Keinan in "The Scientist"

May, 2019 Artificial Intelligence Shakes Up Drug Discovery - Bianca Nogrady

Cloud Pharmaceuticals to Present AI-Based Drug Design at Conferences in May
April 30, 2019

Cloud Pharmaceuticals Wins U.S.- China Health Innovation Competition 
October 24, 2018

Cloud Pharmaceuticals Forms Drug Discovery Collaboration with GSK 
May 30, 2018

Cloud Pharmaceuticals CEO to Speak at the Artificial Intelligence in Drug Development Congress, 27-28 September 2017 in London
September 10, 2017

Cloud Pharmaceuticals CEO  to Speak at The AI in Pharma Summit, October 17, 2017 in Boston
August 8, 2017

Cloud Pharmaceuticals CEO and CSO to Speak at AI Pharma Innovation, July 26-27, 2017 in Boston
July 17, 2017

Undruggable? Not to Cloud Pharmaceuticals
February 23, 2017

Cloud Pharmaceuticals Announces Crowdfunding Campaign to Aid in Drug Discovery for ALS and Zika Virus Research
September 28, 2016

Cloud Pharmaceuticals Announces Design of Active Pro-Drug for Treatment of Crohn's Disease and Ulcerative Colitis
June 29, 2016


Cloud Pharmaceuticals COO to Discuss Digital Tools for Drug Discovery and Development at the 2016 BIO International Convention
May 24, 2016

Cloud Pharmaceuticals Announces Completion of 17 Computational Drug Discovery Projects and Resulting Development Programs
February 2, 2016


Cloud Pharmaceuticals Announces Participation at Upcoming #Biotech, Life Sciences and Partnering Events
January 6, 2016



HOME | COMPANY | TECHNOLOGY | PARTNERING | NEWS | EVENTS | CONTACT

CONTACT US:

Cloud Pharmaceuticals, Inc.

Office: 800 Park Offices Dr., RTP, NC 27709
Mail: PO Box 110081, RTP, NC 27709
Phone: 1.910.398.1200
e-mail: info@cloudpharmaceuticals.com
CONNECT WITH US:


SUBSCRIBE:

Join our contact list to receive news and announcements in your inbox:

Join Now
© 2014 - 2019 Cloud Pharmaceuticals, Inc. | Terms and Conditions of access to www.cloudpharmaceuticals.com